Drug Topics November 13, 2024
Brian Nowosielski

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.

In order to maintain the integrity of the US drug supply chain, it’s the shared goal of pharmacists, manufacturers, and regulators to focus on protecting all pharmaceutical products, and ultimately the patient receiving those products, from harm. From enforcement actions and warning letters to new programs furthering the organization’s mission, the FDA is working around the clock with several supply chain contributors to ensure safety and security within US pharmacies.

“We need to make sure that our federal requirements, layered with our state requirements, maintain the integrity of the pharmaceutical supply chain to protect the product and ultimately protect the patient. That’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Pharma, Pharma / Biotech, Trends
Related Articles:
FDA updates definition of 'healthy'
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
4 takeaways from the FDA’s first digital health advisory committee
FDA commissioner, a veteran cardiologist, highlights ongoing issues with US healthcare system
FDA commissioner urges health systems to strengthen AI quality oversight

Share This Article